This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 13:02, 20 April 2011 (Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 13:02, 20 April 2011 by CheMoBot (talk | contribs) (Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation ()(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (February 2010) |
 | |
| Names | |
|---|---|
| IUPAC name N-Methyl-N-pentylnitrous amide | |
| Other names Methylamylnitrosamine | |
| Identifiers | |
| CAS Number | |
| 3D model (JSmol) | |
| Abbreviations | MNAN |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
SMILES
| |
| Properties | |
| Chemical formula | C6H14N2O |
| Molar mass | 130.19 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
 Y verify (what is ?)
Infobox references
| |
Methyl-n-amylnitrosamine (MNAN) is a potential carcinogen It is metabolized in the liver by the enzyme CYP2A6.
References
- Bulay O, Mirvish SS (1979). "Carcinogenesis in rat esophagus by intraperitoneal injection of different doses of methyl-n-amylnitrosamine". Cancer Res. 39 (9): 3644–6. PMID 476689.
{{cite journal}}: Unknown parameter|month=ignored (help)
 | This article about an organic compound is a stub. You can help Misplaced Pages by expanding it. |